CANOPY GROWTH CORP (OTCMKTS:TWMJF) continues to set the standard for players in the Canadian cannabis patch during the second half of 2017, rising as much as 183% since early July on a number of catalysts, including the company’s ability to court big money investment from sources not historically associated with the cannabis space.

The latest from the company is its recent announcement that it has entered into a distribution agreement with Winnipeg-based Delta 9 Cannabis Inc. (TSX.V: NINE), an existing Licensed Producer under the Access to Cannabis for Medical Purposes Regulations. According to the release, Delta 9 will offer their well-established cannabis products through Canopy Growth’s curated CraftGrow line via Tweed Main Street’s online store, alongside other high-quality cannabis varieties grown by a diverse set of producers.

CANOPY GROWTH CORP (OTCMKTS:TWMJF) is one of the bigger growers. The company produces and sells medical marijuana in Canada. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. It also sells its products through online.

According to company materials, “Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.”

Also from their materials, “Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.”

Find out when $TWMJF stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

As noted above, shares of the stock have continued to hold up in the wake of its recent high-profile breakout. The company just added to its list of recent catalysts with its announcement that it has entered into a distribution agreement with another licensed producer in Canada.

According to the release, “Delta 9 was founded in 2012, and quickly became the fourth fully licensed producer and distributor of medical cannabis in Canada. Currently operating an 80,000 sq. ft. production facility in East Winnipeg, Delta 9 is focused on growing small batch, hand trimmed medical cannabis strains in its innovative, self-designed Grow Pod systems. As Manitoba has recently unveiled its proposed cannabis distribution model, which includes private sales, Delta 9 will work with Canopy Growth to continue to serve the local market with consistent high-quality standardized cannabis products, while gaining access to consumers across the country through Canopy Growth’s online marketplace.”

“We recognize the varied needs of our patients and through the CraftGrow program we aim to bring them the highest quality products from a variety of producers that each bring a unique offering forward,” said Mark Zekulin, President of Canopy Growth Corporation. “This is the ninth participant in the CraftGrow program, and we are particularly excited to see one of the earliest established producers in our sector come on board. We want to promote the value of our platform approach and welcoming Delta 9’s products to our shop speaks volumes to the CraftGrow program’s potential.”

Earning a current market cap value of $1490.8M, TWMJF has a significant war chest ($108.9M) of cash on the books, which stands against about $1.6M in total current liabilities. TWMJF is pulling in trailing 12-month revenues of $57.9M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 106.7%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $TWMJF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $TWMJF, either long or short, and we have not been compensated for this article.